Top
Note: You're navigating the results of models obtained with the previous release of IntOGen (2020). A new boostDM version corresponding to the current IntOGen release will be available soon.
EZH2 DLBCL ×
Select a mutation to see further information
Mutation AA change Consequence type BoostDM score IntOGen frequency
7:148811635:A Y646F missense_variant 1.00 12
7:148811636:T Y646N missense_variant 1.00 10
7:148811636:G Y646H missense_variant 1.00 5
7:148809375:C A682G missense_variant 1.00 3
7:148809345:A A692V missense_variant 1.00 2
7:148811635:G Y646S missense_variant 1.00 1
7:148811636:C Y646D missense_variant 1.00 0
7:148809345:C A692G missense_variant 1.00 0
7:148809345:T A692E missense_variant 1.00 0
7:148809375:T A682E missense_variant 1.00 0
7:148809375:A A682V missense_variant 1.00 0
7:148811635:C Y646C missense_variant 1.00 0
7:148811634:C Y646* stop_gained 1.00 0
7:148811634:T Y646* stop_gained 1.00 0
7:148809346:A A692S missense_variant 0.99 0
7:148809346:T A692T missense_variant 0.99 0
7:148809376:T A682T missense_variant 0.99 0
7:148809376:G A682P missense_variant 0.99 0
7:148809376:A A682S missense_variant 0.99 0
7:148809346:G A692P missense_variant 0.99 0
In silico saturation mutagenesis
Alt text Show figure caption
Cancer type Selected cancer type Mutational discovery Index Feature Complexity
(DLBCL) Diffuse large B-cell lymphoma DLBCL 0.92 0.07